RxSight, Inc.
Income Statement
| Line Item | Jun 2022 | Mar 2022 | Dec 2021 | Sep 2021 | Jun 2021 | Mar 2021 | Sep 2020 | Jun 2020 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $11.4M | $8.9M | $8.4M | $5.8M | $4.9M | $3.5M | $4.2M | $2.7M |
| Cost of Revenue | $6.6M | $5.2M | $5.6M | $4.4M | $5.7M | $2.4M | $3.5M | $3.2M |
| Gross Profit | $4.8M | $3.8M | $2.9M | $1.3M | $-812.0K | $1.1M | $720.0K | $-474.0K |
| Gross Margin | 42.1% | 42.1% | 34.0% | 23.2% | -16.6% | 32.1% | 17.3% | -17.5% |
| Operating Expenses | ||||||||
| Research & Development | $6.2M | $6.7M | $5.9M | $5.4M | $6.6M | $6.6M | $5.8M | $5.1M |
| SG&A Expense | $14.4M | $13.6M | $11.6M | $9.1M | $6.5M | $5.6M | $3.8M | $3.2M |
| Operating Income | $-15.8M | $-16.6M | $-14.7M | $-13.1M | $-13.9M | $-11.1M | $-8.9M | $-8.8M |
| Operating Margin | -139.0% | -185.4% | -174.0% | -226.6% | -283.4% | -319.6% | -213.6% | -325.5% |
| Interest Expense | $1.1M | $1.1M | $1.1M | $1.1M | $826.0K | $698.0K | $3.0K | $4.0K |
| Pretax Income | $-16.7M | $-17.6M | $-15.7M | $-12.7M | $-13.5M | $-6.8M | $30.7M | $-12.8M |
| Income Tax Expense | $0 | $4.0K | $2.0K | $-4.0K | $3.0K | $7.0K | $8.0K | $40.0K |
| Net Income | $-16.7M | $-17.6M | $-15.7M | $-12.7M | $-13.5M | $-6.8M | $30.7M | $-12.9M |
| Net Margin | -147.3% | -196.8% | -186.7% | -219.0% | -275.2% | -195.3% | 735.3% | -476.1% |
| EPS (Basic) | $-0.31 | $-0.32 | $1.05 | $-0.17 | $-0.82 | $-0.43 | $0.00 | $0.00 |
| EPS (Diluted) | $-0.31 | $-0.32 | $1.17 | $-0.17 | $-0.88 | $-0.43 | $0.00 | $0.00 |
| Shares Outstanding (Basic) | 55.1M | 54.9M | 54.7M | 74.9M | 16.4M | — | 0 | 0 |
| Shares Outstanding (Diluted) | 55.1M | 54.9M | 54.7M | 74.9M | 16.7M | — | 0 | 0 |
| Dividends Per Share | — | — | — | — | — | — | — | — |